Dr. Witt-Doerring has had the privilege of helping several patients with litigation related to psychiatric drug injuries, thanks to his prior experience as a Medical Officer in the Division of Psychiatry at the Food and Drug Administration. There, he analyzed emergent adverse drug reactions and proposed modifications to drug labeling, giving him a unique perspective on the risks and benefits of psychiatric interventions in both the short and long term.

In addition, Dr. Witt-Doerring has worked at numerous pharmaceutical companies in clinical research and drug safety positions, bringing valuable experience from both the regulatory and clinical settings to his practice. He completed a fellowship in Psychiatric Drug Development at Janssen Research & Development and Drexel College of Medicine, as well as his psychiatric residency at Baylor College of Medicine, and earned his medical degree from the University of Queensland Medical School in Australia.